Literature DB >> 7345574

Induced hypertension chemotherapy of cancer patients by selective enhancement of drug delivery to tumor tissue with angiotensin II.

H Sato, K Sato, Y Sato, M Asamura, R Kanamaru, Z Sugiyama, T Kitahara, Y Mimata, A Wakui, M Suzuki, K Hori, I Abe, S Saito, H Sato.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7345574

Source DB:  PubMed          Journal:  Sci Rep Res Inst Tohoku Univ Med        ISSN: 0371-2761


× No keyword cloud information.
  11 in total

1.  Functional characterization of the microcirculation in tumors.

Authors:  M Suzuki; K Hori; I Abe; S Saito; H Sato
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

2.  Angiotensin II (AII) induced hypertension chemotherapy (IHC) for unresectable gastric cancer: with reference to resection after down staging.

Authors:  H Sato; K Sugiyama; M Hoshi; M Urushiyama; K Ishizuka
Journal:  World J Surg       Date:  1995 Nov-Dec       Impact factor: 3.352

3.  Angiotensin-II administration is useful for the detection of liver metastasis from pancreatic cancer during pharmacoangiographic computed tomography.

Authors:  Toru Ishikawa; Takashi Ushiki; Hiroteru Kamimura; Tadayuki Togashi; Atsunori Tsuchiya; Kouji Watanabe; Keiichi Seki; Hironobu Ohta; Toshiaki Yoshida; Keiko Takeda; Tomoteru Kamimura
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

Review 4.  Some aspects of size-dependent differential drug response in primary and metastatic tumors.

Authors:  I Abe; M Suzuki; K Hori; S Saito; H Sato
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

Review 5.  Clinical Experience With IV Angiotensin II Administration: A Systematic Review of Safety.

Authors:  Laurence W Busse; Xueyuan Shelly Wang; Divya M Chalikonda; Kevin W Finkel; Ashish K Khanna; Harold M Szerlip; David Yoo; Sharon L Dana; Lakhmir S Chawla
Journal:  Crit Care Med       Date:  2017-08       Impact factor: 7.598

6.  Augmentation of tumour delivery of macromolecular drugs with reduced bone marrow delivery by elevating blood pressure.

Authors:  C J Li; Y Miyamoto; Y Kojima; H Maeda
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

7.  Fluctuations in tumor blood flow under normotension and the effect of angiotensin II-induced hypertension.

Authors:  K Hori; M Suzuki; S Tanda; S Saito; M Shinozaki; Q H Zhang
Journal:  Jpn J Cancer Res       Date:  1991-11

8.  Increased intratumor concentration of fluorescein-isothiocyanate-labeled neocarzinostatin in rats under angiotensin-induced hypertension.

Authors:  I Abe; K Hori; S Saito; S Tanda; Y L Li; M Suzuki
Journal:  Jpn J Cancer Res       Date:  1988-07

9.  Comparison of the effects of intravenously bolus-administered endothelin-1 and infused angiotensin II on the subcutaneous tumor blood flow in anesthetized rats.

Authors:  S Tanda; K Hori; S Saito; M Shinozaki; Q H Zhang; M Suzuki
Journal:  Jpn J Cancer Res       Date:  1991-08

10.  Effects of intravenous infusion of dopamine on tumor blood flow in rat subcutis.

Authors:  S Tanda; K Hori; S Saito; Q H Zhang; H C Li; M Suzuki
Journal:  Jpn J Cancer Res       Date:  1994-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.